Search research articles
Contact Us
Filters
Showing results (81-90 of 100) with videos related to
Page
of 10
Sort By:
Journal for Immunotherapy of Cancer
|
September 4, 2021
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer
Peter J DeMaria, Katherine Lee-Wisdom, Renee N Donahue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2021
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas
Brian D Weiss, Pamela L Wolters, Scott R Plotkin, et al.
Sarcoma
|
November 16, 2017
SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors
Christine S Higham, Seth M Steinberg, Eva Dombi, et al.
The New England Journal of Medicine
|
December 29, 2016
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Eva Dombi, Andrea Baldwin, Leigh J Marcus, et al.
Communications Biology
|
October 11, 2018
Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1
Sara H Isakson, Anthony E Rizzardi, Alexander W Coutts, et al.
Neuro-Oncology
|
April 25, 2022
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity
Andrea M Gross, Brittany Glassberg, Pamela L Wolters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
Srivandana Akshintala, R Taylor Sundby, Donna Bernstein, et al.
Cell Reports
|
February 25, 2016
Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation
Jianqiang Wu, Vincent W Keng, Deanna M Patmore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2026
SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST)
AeRang Kim, Karla V Ballman, Pamela L Wolters, et al.
Neuro-Oncology
|
June 3, 2022
Management of neurofibromatosis type 1-associated plexiform neurofibromas
Michael J Fisher, Jaishri O Blakeley, Brian D Weiss, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 100) with videos related to
Sort By:
Page
of 10
Journal for Immunotherapy of Cancer
|
September 4, 2021
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer
Peter J DeMaria, Katherine Lee-Wisdom, Renee N Donahue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2021
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas
Brian D Weiss, Pamela L Wolters, Scott R Plotkin, et al.
Sarcoma
|
November 16, 2017
SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors
Christine S Higham, Seth M Steinberg, Eva Dombi, et al.
The New England Journal of Medicine
|
December 29, 2016
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Eva Dombi, Andrea Baldwin, Leigh J Marcus, et al.
Communications Biology
|
October 11, 2018
Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1
Sara H Isakson, Anthony E Rizzardi, Alexander W Coutts, et al.
Neuro-Oncology
|
April 25, 2022
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity
Andrea M Gross, Brittany Glassberg, Pamela L Wolters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
Srivandana Akshintala, R Taylor Sundby, Donna Bernstein, et al.
Cell Reports
|
February 25, 2016
Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation
Jianqiang Wu, Vincent W Keng, Deanna M Patmore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2026
SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST)
AeRang Kim, Karla V Ballman, Pamela L Wolters, et al.
Neuro-Oncology
|
June 3, 2022
Management of neurofibromatosis type 1-associated plexiform neurofibromas
Michael J Fisher, Jaishri O Blakeley, Brian D Weiss, et al.
Page
of 10